Article Information
History
- July 23, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lucy Ireland1,
- Almudena Santos1,
- Fiona Campbell1,
- Carlos Figueiredo1,
- Lesley Ellies3,
- Ulrike Weyer-Czernilofsky2,
- Thomas Bogenrieder4,5,
- Michael Schmid1 and
- Ainhoa Mielgo1,*
- 1Department of Molecular and Clinical Cancer Medicine. University of Liverpool. Liverpool L69 3GE, UK
- 2Boehringer Ingelheim RCV GmbH & Co KG Pharmacology and Translational Research, Vienna A-1121, Austria
- 3Department of Pathology. University of California San Diego. La Jolla, CA-92093. U.S.A.
- 4Boehringer Ingelheim RCV GmbH & Co KG Medicine and Translational Research, Vienna, Austria
- 5Department of Urology, University Hospital Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377 Munich, Germany
- ↵*correspondence
author to whom correspondence should be addressed: Dr Ainhoa Mielgo, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, First Floor Sherrington Building, Ashton street, Liverpool L69 3GE, Phone: +44 (0) 151 794 9555, e-mail: amielgo{at}liverpool.ac.uk